Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE Here, a 22 year old female with angiographically proven BCS secondary to JAK2/V617F positive Polycythemia vera on therapeutic warfarin presented with acute liver failure (ALF). 26626649 2016
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 CausalMutation CLINVAR Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis. 25698270 2015
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE The JAK2 V617F mutation was identified in six of 28 patients (21.4%) with idiopathic PVT or BCS and in eight of 45 patients (17.8%) with PVT or BCS secondary to a known prothrombotic factor, but in only one of 38 patients (2.6%) with PVT and cirrhosis (p=0.049). 25698270 2015
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 CausalMutation CLINVAR JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients. 23980667 2014
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 CausalMutation CLINVAR Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: a single-center study. 23425079 2013
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE These results suggest that the JAK2-V617F mutation occurs after the onset of monoclonal haematopoiesis; thus the V617F mutation of JAK2 may not be the primary event in the induction of BCS. 19308656 2009
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 CausalMutation CLINVAR The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. 19293426 2009
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE Determination of the JAK2 V617F mutation may be useful to recognize patients with Budd-Chiari syndrome with or at risk for the subsequent development of overt myeloproliferative diseases. 18600100 2008
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 CausalMutation CLINVAR Determination of the JAK2 V617F mutation may be useful to recognize patients with Budd-Chiari syndrome with or at risk for the subsequent development of overt myeloproliferative diseases. 18600100 2008
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. 16762626 2006
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 CausalMutation CLINVAR Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. 16762626 2006
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE JAK2 V617F was identified in 35.6% of 73 patients with EHPVO and in 40% of 20 patients with BCS. 17133457 2006
Budd-Chiari Syndrome
CUI: C0856761
Disease: Budd-Chiari Syndrome
0.770 GeneticVariation BEFREE The purpose of this study was to use JAK2 V617F analysis to re-evaluate the validity of elevated Epo levels as a PV-exclusion criterion in patients with hepatic vein thrombosis [Budd-Chiari syndrome (BCS)]. 16827884 2006